Treatment of the psychological and behavioural disorders of Alzheimer's disease;Maladie d'Alzheimer, traitement des troubles psychologiques et comportementaux

Presse Medicale

Volumn 34, Issue 9, 2005, Pages 667-672

  Pancrazi, M P ^a   Metais, P ^b  

^a Hopital Notre Dame de Bonne Secours   (France)

^b NONE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; ANXIOLYTIC AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; BENZAMIDE; BENZODIAZEPINE; CARBAMAZEPINE; CHOLINESTERASE INHIBITOR; HYPNOTIC SEDATIVE AGENT; MEMANTINE; MIANSERIN; MOCLOBEMIDE; MONOAMINE OXIDASE A INHIBITOR; NEUROLEPTIC AGENT; OLANZAPINE; OXAZEPAM; PHENOTHIAZINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; TIAPRIDE; VALPROIC ACID;

AGGRESSION; AGITATION; ALZHEIMER DISEASE; ANTICHOLINERGIC EFFECT; ANXIETY DISORDER; BEHAVIOR DISORDER; BEHAVIOR THERAPY; CAREGIVER; COGNITIVE DEFECT; CONSTIPATION; DELIRIUM; DEPRESSION; ELECTROCONVULSIVE THERAPY; EMOTIONAL DISORDER; EXTRAPYRAMIDAL SYMPTOM; HOME CARE; HUMAN; MENTAL DISEASE; MUSIC THERAPY; NEUROLOGIC DISEASE; PARKINSONISM; PHOTOTHERAPY; PSYCHOLOGICAL ASPECT; PSYCHOPHARMACOTHERAPY; PSYCHOSIS; REVIEW; SEDATION; SIDE EFFECT; SLEEP DISORDER; TARDIVE DYSKINESIA; URINE RETENTION;

EID: 20144375356     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0755-4982(05)84011-4     Document Type: Review

References (45)

1. Finkel SI, Coste Silva J, Cohen G, Miller S, Sartorius N. Behavioural and psychological signs and symptoms of dementia: a consensus statement on current knowledge and implications for research and treatment. Int Psychogeriatr 1996; 8 (suppl3): 497-500.
2. Lebert F, Pasquier F. Les symptômes comportementaux et psychologiques de la démence. Encyclopédie Médico chirurgicale de Neurologie 1999; 17-057-A-35.
3. Touchon J, Portet F, Ritchie K. Troubles psychocomportementaux dans la maladie d'Alzheimer. Rev Prat 1998; 48: 1898-905.
4. Whitehouse PJ, Orgogozo JM, Becker R. Quality of life assessment in dementia drug development. Alzheimer Dis Assoc Disord 1997; 11 (Suppl3): 56-60.
5. Kaufer DI, Cummings JL, Christine D, Bray T, Castellon S, Masterman D. Assessing the impact of neuropsychiatric symptoms in Alzheimer's disease: the neuropsychiatric inventory caregiver distress scale. J Am Geriatr Soc 1998; 46: 210-15.
6. American Psychiatric Association Practice Guideline for the treatment of patients with Alzheimer's Disease and other dementias of late life. Am J Psychiatry 1997 (suppl): 1-38.
7. Doody RS, Stevens JC, Beck C, Dubinsky RM, Kaye JA, Gwyther L. Management of dementia (an evidence-based review). Report of the quality standards subcomittee of the American academy of neurology. Neurology 2001; 56: 1154-66.
8. Proulx G, Fontanier D. Clément J-P, Lafont V, Robert P. Traitements non pharmacologiques des troubles cognitifs et comportementaux chez le sujet âgé. Encyclopédie Médico Chirurgicale de Psychiatrie 37-540-045,2001, 6 p.
9. Zanetti O, Trabucchi M. Non-pharmacological treatment of Alzheimer's disease. In: Dementias. S Govoni, CL Bous, M Trabucchi (Eds). Ed Spriger, 1999.
10. Herrmann N. Recommendations for the management of behavioral and psychological symptoms of dementia. Can J Neurol Sci 2001; 28 Suppl 1:S96-107.
11. Pancrazi MP, Métais P. Approches non pharmacologiques dans la maladie d'Alzheimer. La Revue du Généraliste et de la Gérontologie 2002; 83: 148-52.
12. Cohen-Mansfield J. Non pharmacologic interventions for inappropriate behaviors in dementia: a review, summary, and critique. Am J Geriatr Psychiatry 2001; 9: 361-81.
13. Pancrazi MP. Place de la psychothérapie dans le prise en charge des sujets déments. In: Attention et Mémoire. J.F. Camus, M.C. Gely Nargeot, B. Michel (edt) Ed Solal Marseille 2000: 281-302.
14. Bizzini L, Campus Souche D. Spécificités du traitement à l'âge avancé: Psychothérapies cognitives In Troubles Psychiatriques à l'âge avancé. Cahiers psychiatriques genevois 1998; 25: 257-77.
15. Le Goues G. Le psychanalyste et le vieillard. Paris, Puf, 1991.
16. Charazac PM. La Psychothérapie des patients déments. In: Introduction aux soins gérontopsychiatriques. Paris, Dunod, 2001: 122-5.
17. Ylieff M. Analyse et traitements comportementaux. In: Guard O. Michel. B. La Maladie d'Alzheimer. Medsi/Mac Graw- Hill 1989: 303-16.
18. Beck CK. Psychosocial and behavioral interventions for Alzheimer's disease patients and their families. Am J Geriatr Psychiatry 1998 Spring; 6(2 Suppl 1): S41-8.
19. Sink KM, Holden KM, Yaffe K. Pharmacological Treatment of Neuropsychiatric Symptoms of Dementia A Rewiew of evidence. JAMA, 2005; 293: 596-608.
20. Haley WE, Bailey S. Recherche sur la prise en charge par la famille dans la maladie d'Alzheimer: implications pratiques et de santé publique. In: Les aidants familiaux et professionnels de la charge à l'aide. Paris, Serdi, 2001: 81-93.
21. Teri L. Behavior and caregiver burden: behavioral problems in patients with Alzheimer disease and its association with caregiver distress. Alzheimer Dis Assoc Disord 1997; 11 Suppl 4: S35-8.
22. Pancrazi MP, Métais P. Vivre avec un proche atteint d'Alzheimer. Dunod Inter Éditions Paris, 2004.
23. Sorensen S, Pinquart M, Duberstein PO. How effective are interventions with caregivers? An updated meta-analysis. Gerontologist 2002; 42: 356-72.
24. Gwyther LP. Family issues in dementia: finding a new normal. Neurol Clin 2000; 18: 993-1010.
25. Gormley N, Lyons D, Howard R. Behavioural management of aggression in dementia: a randomized controlled trial. Age Ageing 2001; 30: 141-5.
26. Reisberg B, Borenstein J, Salob S, Ferris SH, Franssen E, Georgotas A. Behavioral symptoms in Alzheimer's disease. Phenomenology and treatment. J Clin Psychiatry 1987; 48(Suppl); 9-15.
27. Cummings JL. Cholinesterase inhibitors: a new class of psychotropic agents. Am J Psychiatry 2000; 157: 4-15.
28. Trinh NH, Hoblyn J, Mohanty S, Yaffe K. Efficacy of cholinesterase inhibitors in the treatment of neuropsychiatric symptoms and functional impairment in Alzheimer disease: a meta-analysis. JAMA 2003; 289: 210-16.
29. Holmes C, Wilkinson D, Dean C, Vethanayagam S, Olivieri S, Langley A et al. The efficacy of donepezil in the treatment of neuropsychiatric symptoms in Alzheimer disease. Neurology 2004; 63: 214-19.
30. Tariot PN, Solomon PR, Morris JC. A 5-month, randomized, placebo-controlled trial of galantamine in AD. Neurology 2000; 54: 2269-76.
31. Mega MS, Masterman DM, O'Connor SM Barclay TR, Cummings JL. The spectrum of behavioral responses to cholinesterase inhibitor therapy in Alzheimer disease. Arch Neurol 1999; 56: 1388-93.
32. Schneider LS, Pollock VE, Lyness, SA. A meta-analysis of controlled trials of neuroleptic treatment in dementia. J Am Geriatr Soc 1990; 38: 553-63.
33. Schneider LS. Meta-analysis of controlled pharmacologic trials. Int Psychogeriatr 1996; 8: 375-9.
34. Pancrazi MP. Impact des neuroleptiques sur les fonctions cognitives chez le sujet âgé. Rev du généraliste et de la gérontologie 1999; 59: 22-6.
35. Jeste DV, Rockwell E, Harris MJ, Lohr JB, Lacro J. Conventional vs. newer antipsychotics in elderly patients. Am J Geriatr Psychiatry 1999; 7: 70-6.
36. Tariot PN, Profenno LA, Smail MS. Efficacy of atypical antipsychotics in elderly patients with dementia. J Clin Psychiatry 2004; 65 (Suppl 11): 11-15.
37. Gill SS, Rochon PA, Herrmann N, Lee PE, Sykora K, Gunraj N et al. Atypical antipsychotic drugs and risk of ischaemic stroke: population based retrospective cohort study. BMJ 2005; 330: 445.
38. Robert PH, Allain H. Clinical management of agitation in the elderly with tiapride. Eur Psychiatry 2001; 16 Suppl 1: 42s-7s.
39. Pancrazi MP. La dépression dans la maladie d'Alzheimer. La revue de Gériatrie 2002; 27-3: 202-6.
40. Burke WJ, Dewan V, Wengel SP, Roccaforte WH, Nadolny GC, Folks DG. The use of selective serotonin reuptake inhibitors for depression and psychosis complicating dementia. Internat J Geriatr Psych 1997; 12: 519-25.
41. Bains J, Birks JS, Dening TR. The efficacy of antidepressants in the treatment of depression in dementia. Cochrane Database Syst Rev. 2002; (4): CD003944.
42. Finkel SI, Mintzer JE, Dysken M, Krishnan KR, Burt T, McRae T. A randomized, placebo-controlled study of the efficacy and safety of sertraline in the treatment of the behavioral manifestations of Alzheimer's disease in outpatients treated with donepezil. Int J Geriatr Psychiatry 2004; 19: 9-18.
43. Derouesné C. Les manifestations non cognitives de la maladie d'Alzheimer. In: Herisson C, Touchon J, Enjalbert J. Maladie d'Alzheimer et médecine de rééducation. Paris, Masson, 1996: 59-68.
44. Roth M, Mountjoy CQ, Amrein R. Moclobemide in elderly patients with cognitive decline and depression: an international double-blind, placebo-controlled trial. Br J Psychiatry 1996; 168: 149-57.
45. Hogan DB, Maxwell CJ, Fung TS, Ebly EM. Prevalence and potential consequences of benzodiazepine use in senior citizens: results from the Canadian Study of Health and Aging. Can J Clin Pharmacol 2003; 10: 72-7.